Benefits of reducing LDL cholesterol among 18,686 patients with diabetes: Meta-analysis of 14 radomized trials of a statin versus control

Benefits of reducing LDL cholesterol among 18,686 patients with diabetes: Meta-analysis of 14 radomized trials of a statin versus control

Bibliographische Detailangaben
Hauptverfasser:	Kearney, P, Blackwell, L, Armitage, J, Keech, T, Simes, J, Collins, R, Baigent, C
Format:	Conference item
Veröffentlicht:	2006

Ähnliche Einträge

Efficacy of cholesterol-lowering therapy in 18,686 people with diabetes in 14 randomised trials of statins: a meta-analysis.
von: Kearney, P, et al.
Veröffentlicht: (2008)

Lack of effect of lowering LDL cholesterol on cancer: meta-analysis of individual data from 175,000 people in 27 randomised trials of statin therapy.
von: Emberson, J, et al.
Veröffentlicht: (2012)

The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials.
von: Mihaylova, B, et al.
Veröffentlicht: (2012)

Efficacy and safety of more intensive lowering of LDL cholesterol Reply
von: Baigent, C, et al.
Veröffentlicht: (2011)

Efficacy and safety of more intensive lowering of LDL cholesterol Reply
von: Baigent, C, et al.
Veröffentlicht: (2011)

Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins.
von: Baigent, C, et al.
Veröffentlicht: (2005)

Statins and diabetes - Authors' reply
von: Kearney, P, et al.
Veröffentlicht: (2008)

Cost-effectiveness of lowering LDL cholesterol with statins and ezetimibe in chronic kidney disease
von: Mihaylova, B, et al.
Veröffentlicht: (2019)

Statins and diabetes - Reply
von: Kearney, P, et al.
Veröffentlicht: (2008)

Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90 056 participants in 14 randomised controlled trials of statins (vol 366, pg 1267, 2005)
von: Baigent, C, et al.
Veröffentlicht: (2008)

LDL cholesterol targets--how low to go?
von: Bulbulia, R, et al.
Veröffentlicht: (2012)

Pharmacogenetic meta-analysis of genome-wide association studies of LDL cholesterol response to statins
von: Postmus, I, et al.
Veröffentlicht: (2014)

Efficacy and safety of cholesterol-lowering treatment - Reply
von: Baigent, C, et al.
Veröffentlicht: (2006)

Efficacy and safety of cholesterol-lowering treatment - Reply
von: Baigent, C, et al.
Veröffentlicht: (2006)

Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials.
von: Baigent, C, et al.
Veröffentlicht: (2010)

Impact of renal function on the effects of LDL cholesterol lowering with statin-based regimens: a meta-analysis of individual participant data from 28 randomised trials
von: Cholesterol Treatment Trialists' Collaboration, et al.
Veröffentlicht: (2016)

Targets of statin therapy: LDL cholesterol, non-HDL cholesterol, and apolipoprotein B in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS).
von: Charlton-Menys, V, et al.
Veröffentlicht: (2009)

Effects of lowering LDL cholesterol on progression of kidney disease.
von: Haynes, R, et al.
Veröffentlicht: (2014)

Statins: are any questions unanswered?
von: Kearney, P, et al.
Veröffentlicht: (2006)

Cholesterol, statins, and mortality - Reply
von: Lewington, S, et al.
Veröffentlicht: (2008)

Lowering LDL cholesterol reduces cardiovascular risk independently of presence of inflammation
von: Storey, B, et al.
Veröffentlicht: (2017)

Cholesterol, statins, and mortality - Authors' reply
von: Lewington, S, et al.
Veröffentlicht: (2008)

Greater absolute reductions in LDL cholesterol should yield greater proportional reductions in risk of cardiovascular disease.
von: Clarke, R, et al.
Veröffentlicht: (2009)

Misrepresentation of statin safety evidence.
von: Armitage, J, et al.
Veröffentlicht: (2014)

Radar scanners and radomes/
von: 452362 Cady, Willoughby Miller, et al.
Veröffentlicht: (1948)

The effect of lowering LDL cholesterol on vascular access patency: post hoc analysis of the Study of Heart and Renal Protection.
von: Herrington, W, et al.
Veröffentlicht: (2014)

Randomized trial of cholesterol-lowering and antioxidant vitamins in 7,000 high-risk individuals with LDL cholesterol below 120 mg/dl
von: Collins, R, et al.
Veröffentlicht: (2002)

The impact of radome on the GPS observation
von: Mat Amin, Zulkarnaini, et al.
Veröffentlicht: (2005)

Integrated radome-antenna system
von: Chua, Clivant You Jie
Veröffentlicht: (2022)

Integrated radome-antenna system
von: Liu, Tianyu
Veröffentlicht: (2022)

Analysis of radome-enclosed antennas /
von: 214681 Kozakoff, Dennis J.
Veröffentlicht: (1997)

The impact of radome on the GPS observation /
von: Zulkarnaini Mat Amin, 1961-, et al.
Veröffentlicht: (2005)

Does the benefit from statin therapy extend beyond 5 years?
von: Bulbulia, R, et al.
Veröffentlicht: (2013)

Does the benefit from statin therapy extend beyond 5 years?
von: Bulbulia, R, et al.
Veröffentlicht: (2013)

A rapid single-step centrifugation method for determination of HDL, LDL, and VLDL cholesterol, and TG, and identification of predominant LDL subclass.
von: Sawle, A, et al.
Veröffentlicht: (2002)

Long-term cardiovascular risks and statin treatment impact on socioeconomic inequalities: microsimulation model
von: Wu, R, et al.
Veröffentlicht: (2023)

Statins for people at low risk of cardiovascular disease reply
von: Mihaylova, B, et al.
Veröffentlicht: (2012)

Lessons from the controversy over statins - Authors' reply.
von: Armitage, J, et al.
Veröffentlicht: (2016)

Benefits of lowering cholesterol in chronic kidney disease Reply
von: Baigent, C, et al.
Veröffentlicht: (2011)

Genetically-predicted effects of LDL cholesterol lowering therapeutic targets on the risk of diabetes
von: Lind, K
Veröffentlicht: (2022)